Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up.

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 28162923)

Published in HPB (Oxford) on February 02, 2017

Authors

Kerri A Ohman¹, Jingxia Liu², David C Linehan³, Marcus C Tan⁴, Benjamin R Tan⁵, Ryan C Fields⁶, Steven M Strasberg⁶, William G Hawkins⁷

Author Affiliations

1: Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
2: Division of Public Health Sciences, Section of Oncologic Biostatistics, Washington University School of Medicine, St. Louis, MO, USA.
3: Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA.
4: Department of Surgery, University of South Alabama Health System, Mobile, AL, USA.
5: Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO, USA.
6: Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA; Alvin J. Siteman Cancer Center, Barnes-Jewish Hospital, and Washington University School of Medicine, St. Louis, MO, USA.
7: Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA; Alvin J. Siteman Cancer Center, Barnes-Jewish Hospital, and Washington University School of Medicine, St. Louis, MO, USA. Electronic address: hawkinsw@wudosis.wustl.edu.

Articles cited by this ↗

Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med (2004) 13.34

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg (1985) 7.14

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg (1999) 6.93

The accordion severity grading system of surgical complications. Ann Surg (2009) 4.45

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group. Cancer (1987) 3.24

Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: a single-institution phase II study. Ann Surg (2008) 2.40

Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer (2005) 2.32

Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys (1995) 2.22

Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg (2003) 1.92

Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma. Arch Surg (2012) 1.91

Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma. J Clin Oncol (2012) 1.90

Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol (2005) 1.37

The natural history of clinically established radiation enteritis. Lancet (1985) 1.21

Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg (2000) 1.20

Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Ann Oncol (2010) 1.17

Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trial. Ann Surg Oncol (2011) 0.84

Interferon-based Adjuvant Chemoradiation for Resected Pancreatic Head Cancer: Long-term Follow-up of the Virginia Mason Protocol. Ann Surg (2016) 0.78

Articles by these authors ⇆

Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic. Oncotarget (2016) 0.76